Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in South Korea / NCT05804786
Recruiting Observational

Prospective Cohort of Diagnostic Bronchoscopy for Peripheral Lung Lesions

NCT05804786 · tracked via the Priya Life Science South Korea tracker
Sponsor
Seoul National University Bundang Hospital
Phase
Observational
Started
2023-04-01
Last updated
2024-05-10

Condition(s) studied

Lung Cancer

Investigational drug(s) / intervention(s)

Guided bronchoscopy

Guided bronchoscopy: It is performed when a pulmonary lesion with a possibility of malignancy is found on chest CT and histological diagnosis and differentiation are required.

Study summary

The primary objective is To evaluate the usefulness and safety of advanced guided bronchoscopy for histological diagnosis of peripheral pulmonary lesions.

The Secondary objective is to establish a strategy that can most effectively use endoscopes for early diagnosis of lung cancer in a real-world care environment by identifying patient/clinical/image/procedure-related characteristics that can optimize the practicality of emerging technologies.

Eligibility

Sex
ALL
Min age
19 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Patients who agreed in writing to participate in this study 2. Adult men and women over 19 years of age 3. Patients who visited the hospital with lung lesions suspected of lung cancer and require a diagnostic biopsy 4. Patients capable of biopsy through guided bronchoscopy Exclusion Criteria: 1\) Patients who are unable to express their opinions and cannot cooperate due to a lack of cognitive function

Primary outcome measure(s)

  • Diagnostic yield at index — Upon reports of pathologic results (up to 2 weeks after bronchoscopy)
    The proportion of pathologic results that leads to a specific malignant or benign

Trial sites (11)

FacilityCityRegionStatus
Dongsan Hospital Keimyung University School of Medicine Daegu South Korea Recruiting
Hallym University Dongtan Sacred Heart Hospital Gyeonggi-do South Korea Recruiting
Chunnam National University Hwasun Hospital Hwasun South Korea Recruiting
Inje University Ilsan Paik Hospital Ilsan South Korea Recruiting
Gyeongsang National University Hospital Jinju South Korea Recruiting
Seoul National University Bundang Hospital Seongnam-si South Korea Recruiting
Asan Medical Center, University of Ulsan College of Medicine Seoul South Korea Recruiting
Gangnam Severence Hospital Seoul South Korea Recruiting
Hanyang University Hostpital Seoul South Korea Recruiting
The Catholic University of Korea, Seoul, Korea Seoul South Korea Recruiting
Pusan National University Yangsan Hospital Yangsan South Korea Recruiting

More Seoul National University Bundang Hospital trials in South Korea

Pepsinogen II and Helicobacter Pylori Test in Gastric Cancer Active, not recruiting
A Study on the Effects of A2 Milk on Gut Beneficial Bacteria Growth and Digestion Improvement Active, not recruiting
Thyroid Hormone Replacement After Coronary Artery Bypass Grafting for Patients With Subclinical Hypothyroidism Recruiting
Dual-chamber Patient-controlled Analgesia for Postoperative Recovery Recruiting
Cilostazol-Ginkgo for Cognitive Function in Elderly Diabetes Recruiting

Other trials for the same condition

Lung Cancer Surgery in Sarcopenia Patients With Old Age Active, not recruiting
Feasibility of Targeted Bronchial Washing for Molecular Testing by Next Generation Sequencing in Early-stage Lung Cancer Active, not recruiting
A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84) Active, not recruiting
A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection Active, not recruiting
Study of Novel Treatment Combinations in Patients With Lung Cancer Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05804786 on ClinicalTrials.gov ↗ ← All trials in South Korea